Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
2035 Mapping Treatment-Induced Adverse Events against HRQoL Questionnaires in Non-Small Cell Lung Cancer: Evaluation of the EORTC QLQ-C30 and QLQ-LC29 Lotte Van der Weijst 1 , Cecilia Pompili 2,3 , Maria Teixeira 4 , Hayat Hamzeh 5 , Claire Piccinin 4 , Madeline Pe 4 1 EORTC, Brussels, Belgium, 2 Institute for Clinical & Applied Health Research, University of Hull, UK, 3 Section of Patient Centred Outcomes Research, University of Leeds, UK, 4 Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium, 5 Leeds Institute of Medical Research, University of Leeds, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2035 Aims This study aims to evaluate the relevance of health-related quality of life (HRQoL) questionnaires in capturing treatment-induced adverse events
Robert Kushner: Well, Mike, I can tell you I became an expert in motivational interviewing, patient-centered care, behavioral change theories and techniques, and using my hands to try to encourage people to make changes
NAC (N-Acetyl-L-Cysteine)Contains the active L form of N-Acetyl-Cysteine (NAC) in a free form to support healthy liver, lungs, immune system, and detoxification
Regional Manufacturing Hubs: China dominates supply, with emerging capacity in Vietnam and the US
Pharmacokinetics: Why They Matter for Switching Tirzepatide has a half-life of approximately 5 days, reaching steady state after 4 weeks of once-weekly dosing
Liposomal glutathione and sublingual formulations have been developed specifically to bypass digestive breakdown
US$ 27.55
US$ 23.50
US$ 23.04
US$ 28.31
